Chemical Biology and Drug Design

article thumbnail

Cover Image

Chemical Biology and Drug Design

Cover Image © molekuul_be/Shutterstock.

100
100
article thumbnail

Cover Image

Chemical Biology and Drug Design

Cover Image © molekuul_be/Shutterstock.

100
100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions

Chemical Biology and Drug Design

The present review explores the intricate relationship between autophagy and proteostasis in the pathogenesis of neurodegenerative diseases along with the therapeutic interventions to mitigate the same. Abstract Neurodegenerative disorders are devastating disorders characterized by gradual loss of neurons and cognition or mobility impairment. The common pathological features of these diseases are associated with the accumulation of misfolded or aggregation of proteins.

Disease 100
article thumbnail

Diosgenin inhibits proliferation and migration of ovarian cancer cells and induce apoptosis via upregulation of PTEN

Chemical Biology and Drug Design

Diosgenin through downregulation of PI3K, Akt, mTOR and upregulation of PTEN inhibits migration and proliferation of OVCAR-3 cancer cells. Abstract Diosgenin, a natural steroidal sapogenin, has recently attracted a high amount of attention, as an effective anticancer agent in ovarian cancer. However, diosgenin mediated anticancer impacts are still not completely understood.

article thumbnail

Melatonin and its bioisosteres as potential therapeutic agents for the treatment of retinopathy of prematurity

Chemical Biology and Drug Design

Administration of melatonin and 3 its bioisosters efficiently normalize VEGF-A and total protein levels and antioxidant activity in vitreous body of newborn rat pups (in oxygen-induced retinopathy model). Novel melatonin analogues could be used as new metabolically stable therapeutic agents for the treatment of retinopathy of prematurity. Abstract We conducted a study on the impact of intraperitoneal injections of melatonin and its three bioisosteres (compounds 1 – 3 ) on the development of oxyg

Treatment 100
article thumbnail

Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC?MS/MS cancer cell entrapment assays

Chemical Biology and Drug Design

Polymerase inhibitor (daclatasvir; DLT) does not induce cell proliferation in variable cell lines. DLT exhibited a superior antiproliferative and anti-CDK1 potential over the nucleoside analogues, especially in the HepG2. This supports the claim that a reduction in HCC development in patients treated with a DAA. Abstract Directly acting antivirals (DAAs) are a breakthrough in the treatment of HCV.

Treatment 100
article thumbnail

Brucine alleviates fibroblast?like synoviocytes dysfunction and inflammation by regulating YY1 during rheumatoid arthritis

Chemical Biology and Drug Design

Brucine suppressed the proliferation, migration, invasion, inflammation, and macrophage M1 polarization, as well as induced apoptosis in RA-FLSs by decreasing YY1 via circ_0139658/miR-653-5p axis. Abstract Brucine is a weak alkaline indole alkaloid with wide pharmacological activities and has been identified to protect against rheumatoid arthritis (RA) process.